Qing You Pang[Author] - Search Results

Year	Number of Results
2017	1
2020	3
2022	2
2023	2
2024	1

1

Integrative multi-omics approach to targeted therapy for glioblastoma.

Koh L, Novera W, Lim SW, Chong YK, Pang QY, Low D, Ang BT, Tang C. Koh L, et al. Among authors: pang qy. Pharmacol Res. 2022 Aug;182:106308. doi: 10.1016/j.phrs.2022.106308. Epub 2022 Jun 14. Pharmacol Res. 2022. PMID: 35714825 Review.

2

Multiplexed RNA profiling by regenerative catalysis enables blood-based subtyping of brain tumors.

Zhang Y, Wong CY, Lim CZJ, Chen Q, Yu Z, Natalia A, Wang Z, Pang QY, Lim SW, Loh TP, Ang BT, Tang C, Shao H. Zhang Y, et al. Among authors: pang qy. Nat Commun. 2023 Jul 17;14(1):4278. doi: 10.1038/s41467-023-39844-0. Nat Commun. 2023. PMID: 37460561 Free PMC article.

3

Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood-Brain Barrier and Glioblastoma.

Lam MS, Aw JJ, Tan D, Vijayakumar R, Lim HYG, Yada S, Pang QY, Barker N, Tang C, Ang BT, Sobota RM, Pavesi A. Lam MS, et al. Among authors: pang qy. Small. 2023 Dec;19(52):e2302280. doi: 10.1002/smll.202302280. Epub 2023 Aug 30. Small. 2023. PMID: 37649234

4

3D genome organization in the epithelial-mesenchymal transition spectrum.

Pang QY, Tan TZ, Sundararajan V, Chiu YC, Chee EYW, Chung VY, Choolani MA, Huang RY. Pang QY, et al. Genome Biol. 2022 May 30;23(1):121. doi: 10.1186/s13059-022-02687-x. Genome Biol. 2022. PMID: 35637517 Free PMC article.

5

Spotlight on the Granules (Grainyhead-Like Proteins) - From an Evolutionary Conserved Controller of Epithelial Trait to Pioneering the Chromatin Landscape.

Sundararajan V, Pang QY, Choolani M, Huang RY. Sundararajan V, et al. Among authors: pang qy. Front Mol Biosci. 2020 Aug 21;7:213. doi: 10.3389/fmolb.2020.00213. eCollection 2020. Front Mol Biosci. 2020. PMID: 32974388 Free PMC article. Review.

6

SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2.

Sundararajan V, Tan M, Zea Tan T, Pang QY, Ye J, Chung VY, Huang RY. Sundararajan V, et al. Among authors: pang qy. Cancers (Basel). 2020 May 2;12(5):1140. doi: 10.3390/cancers12051140. Cancers (Basel). 2020. PMID: 32370157 Free PMC article.

7

Dual p38MAPK and MEK inhibition disrupts adaptive chemoresistance in mesenchymal glioblastoma to temozolomide.

Cheng HS, Chong YK, Lim EKY, Lee XY, Pang QY, Novera W, Marvalim C, Lee JXT, Ang BT, Tang C, Tan NS. Cheng HS, et al. Among authors: pang qy. Neuro Oncol. 2024 Feb 16:noae028. doi: 10.1093/neuonc/noae028. Online ahead of print. Neuro Oncol. 2024. PMID: 38366847

8

Inhibition of the H3K9 methyltransferase G9A attenuates oncogenicity and activates the hypoxia signaling pathway.

Ho JC, Abdullah LN, Pang QY, Jha S, Chow EK, Yang H, Kato H, Poellinger L, Ueda J, Lee KL. Ho JC, et al. Among authors: pang qy. PLoS One. 2017 Nov 16;12(11):e0188051. doi: 10.1371/journal.pone.0188051. eCollection 2017. PLoS One. 2017. PMID: 29145444 Free PMC article.

9

Correction: Sundararajan, V., et al. SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2. Cancers 2020, 12, 1140.

Sundararajan V, Tan M, Tan TZ, Pang QY, Ye J, Chung VY, Huang RY. Sundararajan V, et al. Among authors: pang qy. Cancers (Basel). 2020 Dec 15;12(12):3777. doi: 10.3390/cancers12123777. Cancers (Basel). 2020. PMID: 33334085 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year